HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	379.21	391.86	382.83	311	309.16	214.93
Other Revenue	9.98	10.48	11.57	9.39	8.55	6.93
Revenue	389.19	402.34	394.41	320.39	317.71	221.86
Revenue Growth (YoY)	-4.30%	2.01%	23.10%	0.84%	43.20%	-14.38%
Cost of Revenue	148.7	145.16	149.41	118.14	98.55	76.4
Gross Profit	240.49	257.18	244.99	202.26	219.16	145.46
Selling, General & Admin	155.86	160.69	140.05	118.76	99.87	69.19
Research & Development	44.36	45.47	46.32	38.11	31.23	23.04
Other Operating Expenses	9.51	6.47	4.83	3.64	3.32	2.48
Operating Expenses	209.74	213.02	191.7	160.25	134.83	95.23
Operating Income	30.75	44.16	53.3	42.01	84.33	50.22
Interest Expense	-2.99	-2.71	-2.53	-1.92	-1.24	-1.89
Interest & Investment Income	0.75	0.89	3.4	6.95	13.08	15.3
Currency Exchange Gain (Loss)	0.43	-0.53	-0.01	-0.15	-0.46	0.01
Other Non Operating Income (Expenses)	-0.29	-0.36	-0.27	-0.18	0	-0
EBT Excluding Unusual Items	28.66	41.46	53.89	46.71	95.72	63.65
Gain (Loss) on Sale of Investments	-	-	0.43	0.22	0.01	-
Gain (Loss) on Sale of Assets	-0.68	-0.75	0.03	-0.47	-0.08	-0.37
Asset Writedown	-1.1	-1.1	-	-	-	-
Other Unusual Items	3.42	1.43	2.28	0.02	3.48	1.82
Pretax Income	30.3	41.03	56.63	46.48	99.13	65.1
Income Tax Expense	1.31	4.23	9.29	4.83	12.93	8.49
Net Income	28.99	36.8	47.33	41.65	86.19	56.62
Net Income to Common	28.99	36.8	47.33	41.65	86.19	56.62
Net Income Growth	-36.62%	-22.24%	13.64%	-51.68%	52.24%	-11.31%
Shares Outstanding (Basic)	63	62	63	63	62	47
Shares Outstanding (Diluted)	64	63	64	63	62	47
Shares Change (YoY)	1.26%	-0.79%	1.35%	2.50%	30.49%	-0.22%
EPS (Basic)	0.46	0.59	0.75	0.66	1.40	1.20
EPS (Diluted)	0.45	0.58	0.74	0.66	1.40	1.20
EPS Growth	-37.41%	-21.62%	12.12%	-52.86%	16.67%	-11.11%
Free Cash Flow	-21.27	-54.15	-75.34	-161.9	-63.09	1.21
Free Cash Flow Per Share	-0.33	-0.85	-1.18	-2.56	-1.02	0.03
Dividend Per Share	0.300	0.300	0.400	0.300	0.530	0.300
Dividend Growth	-25.00%	-25.00%	33.33%	-43.40%	76.67%	-
Gross Margin	61.79%	63.92%	62.12%	63.13%	68.98%	65.56%
Operating Margin	7.90%	10.98%	13.51%	13.11%	26.54%	22.64%
Profit Margin	7.45%	9.15%	12.00%	13.00%	27.13%	25.52%
Free Cash Flow Margin	-5.46%	-13.46%	-19.10%	-50.53%	-19.86%	0.55%
EBITDA	83.22	83.31	86.41	68.95	104.06	65.62
EBITDA Margin	21.38%	20.71%	21.91%	21.52%	32.76%	29.58%
D&A For EBITDA	52.47	39.14	33.12	26.94	19.73	15.4
EBIT	30.75	44.16	53.3	42.01	84.33	50.22
EBIT Margin	7.90%	10.98%	13.51%	13.11%	26.54%	22.64%
Effective Tax Rate	4.31%	10.31%	16.41%	10.39%	13.05%	13.04%
Revenue as Reported	389.19	402.34	394.41	320.39	317.71	221.86
Advertising Expenses	-	10.05	9.61	8.73	6.51	5.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.